Hansen Carl L. G.
Insider CIK 1834412 · ABCL Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics Inc. | A Award deriv | 2026-01-01 | 2026-01-05 | 2,106,505 | — | $0 | 13,096,837 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2025-01-01 | 2025-01-03 | 2,730,109 | — | $0 | 10,990,332 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2024-11-25 | 2024-11-26 | 56,125 | — | $0 | 8,260,223 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2024-11-25 | 2024-11-26 | 56,125 | $2.70 | $151.5K | 898,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2024-09-20 | 2024-09-24 | 56,125 | — | $0 | 8,316,348 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2024-09-20 | 2024-09-24 | 56,125 | $2.70 | $151.5K | 841,875 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2024-05-31 | 2024-06-03 | 56,125 | — | $0 | 8,372,473 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2024-05-31 | 2024-06-03 | 56,125 | $2.70 | $151.5K | 785,750 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2024-02-26 | 2024-02-27 | 56,125 | — | $0 | 8,428,598 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2024-02-26 | 2024-02-27 | 56,125 | $2.70 | $151.5K | 729,625 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2024-01-14 | 2024-01-16 | 2,095,532 | — | $0 | 8,484,723 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2023-11-23 | 2023-11-27 | 56,125 | — | $0 | 6,389,191 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2023-11-23 | 2023-11-27 | 56,125 | $2.70 | $151.5K | 673,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2023-08-24 | 2023-08-25 | 56,125 | — | $0 | 6,445,316 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2023-08-24 | 2023-08-25 | 56,125 | $2.70 | $151.5K | 617,375 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2023-05-26 | 2023-05-30 | 56,125 | — | $0 | 6,501,441 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2023-05-26 | 2023-05-30 | 56,125 | $2.70 | $151.5K | 561,250 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2023-02-22 | 2023-02-23 | 56,125 | — | $0 | 6,557,566 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2023-02-22 | 2023-02-23 | 56,125 | $2.70 | $151.5K | 505,125 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2022-12-01 | 2022-12-05 | 925,069 | — | $0 | 6,613,691 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2022-11-18 | 2022-11-21 | 56,125 | — | $0 | 5,688,622 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2022-11-18 | 2022-11-21 | 56,125 | $2.70 | $151.5K | 449,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2022-08-18 | 2022-08-22 | 56,125 | — | $0 | 5,744,747 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2022-08-18 | 2022-08-22 | 56,125 | $2.70 | $151.5K | 392,875 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2022-05-18 | 2022-05-19 | 56,125 | — | $0 | 5,800,872 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2022-05-18 | 2022-05-19 | 56,125 | $2.70 | $151.5K | 336,750 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2022-02-22 | 2022-02-25 | 56,125 | — | $0 | 5,856,997 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2022-02-22 | 2022-02-25 | 56,125 | $2.70 | $151.5K | 280,625 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2021-12-07 | 2021-12-09 | 920,312 | — | $0 | 5,913,122 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2021-11-18 | 2021-11-22 | 224,500 | — | $0 | 4,992,810 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2021-11-18 | 2021-11-22 | 224,500 | $15.03 | $3.37M | 224,500 | SEC↗ |
| ABCL AbCellera Biologics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 5,598,420 | $24.03 | $134.53M | 55,604,330 | SEC↗ |
| ABCL AbCellera Biologics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 401,580 | $25.50 | $10.24M | 233,500 | SEC↗ |